Early Access — free while we kick the tires
EdgarHawk

Gross Jane A

Director

Director
1 filing analyzed · 1 company · Latest 2025-03-17

Companies

Company Buys Sells Direction
aTYR PHARMA INC ATYR 1 0 Net buying

Activity

March 2025
2025-03-17 aTYR PHARMA INC ATYR
medium
Buy
3,750 shares
$15,000
Significance 5/10

Director Jane A. Gross bought 3,750 shares of ATYR at $4.00; holdings surge 62.5% to 9,750 shares amid unprofitable operations and -33.4% annual revenue decline.

Director Jane A. Gross purchased 3,750 shares at $4.00 on 2025-03-17, increasing her stake by 62.5% from 6,000 to 9,750 shares. The transaction occurs in the context of a company with revenue of $0.00 in the latest quarter, a net loss of $-17,259,000.00 for the full fiscal year, and annual revenue declining 33.4% year-over-year. The current stock price of $4.01 reflects a +17.6% 30-day gain and +30.2% 90-day gain, positioning the stock within 9.5% of its 52-week high of $4.43. A director's choice to substantially increase shareholdings during a period of severe profitability challenges and shrinking revenue warrants scrutiny regarding underlying business outlook or strategic developments not yet publicly reflected in near-term financials.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access